Top Midday Decliners

MT Newswires Live04:06

Bright Minds Biosciences (DRUG) said Monday that the US Food and Drug Administration placed a partial clinical hold on its investigational new drug application for BMB-101, which is being developed to treat developmental and epileptic encephalopathies.

Shares plunged 52% as intraday trading volume rose to over 1.35 million from a daily average of about 128,000.

Marvell Technology (MRVL) has agreed to acquire optical and photonic products maker Lumentum (LITE) in an all-stock deal worth about $115 billion, as the companies aim to create a leader in artificial intelligence connectivity.

Lumentum slumped 17%, with intraday trading volume surging to 11.9 million from a daily average of 4.92 million. Marvell fell 13% as intraday trading volume climbed to almost 45.2 million from a daily average of over 21.7 million.

Price: 26.00, Change: -28.98, Percent Change: -52.71

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment